Rheos Medicines, Inc.
BioTech/Drugs - Cambridge, MA, US
Rheos Medicines, Inc. Employees
Rheos Medicines, Inc. Senior Management
Rheos Medicines, Inc. Details
Rheos Medicines is a biopharmaceutical company harnessing insights in immunometabolism to develop a novel class of medicines with potential to transform the lives of patients with immune mediated diseases. We are rapidly applying a first-in-field approach in immunometabolism with a comprehensive, systems-biology understanding of the metabolic pathways that drive immune cell function and fate coupled to a biomarker discovery effort with potential to bring precision to the treatment of immune-mediated diseases. Launched in 2018 by Third Rock Ventures with a $60 million Series A financing, Rheos is built on groundbreaking science from pioneers in the field, our passionate team of more than 35 employees is advancing a novel pipeline of immunometabolism drugs, and in December 2019, we entered into a worldwide collaboration with Roche to identify and develop new therapeutics for autoimmune and inflammatory disease. We have brought together leading scientists whose discoveries opened the field of immunometabolism, clinicians with a deep understanding of immune-mediated diseases, and an experienced leadership team that integrates immunology, metabolism, computational biology, and drug discovery to unlock a new frontier in precision medicine for immune mediated disease.
Rheos Medicines, Inc. Technologies
Email Providers
Outlook
Domain Name Services
EasyDNS
Support and Feedback
Zendesk
Email Delivery
Mailchimp Mandrill
Hosting
GoDaddy Hosting